These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27697661)

  • 1. Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemia.
    Shimizu R; Muto T; Aoyama K; Choi K; Takeuchi M; Koide S; Hasegawa N; Isshiki Y; Togasaki E; Kawajiri-Manako C; Nagao Y; Tsukamoto S; Sakai S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Iseki T; Starczynowski DT; Iwama A; Yokote K; Nakaseko C
    Leuk Res; 2016 Nov; 50():85-94. PubMed ID: 27697661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia.
    Agrawal S; Hofmann WK; Tidow N; Ehrich M; van den Boom D; Koschmieder S; Berdel WE; Serve H; Müller-Tidow C
    Blood; 2007 May; 109(9):3895-905. PubMed ID: 17234736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia.
    Mullican SE; Zhang S; Konopleva M; Ruvolo V; Andreeff M; Milbrandt J; Conneely OM
    Nat Med; 2007 Jun; 13(6):730-5. PubMed ID: 17515897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation silencing of the Apaf-1 gene in acute leukemia.
    Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y
    Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nr4a3, a possibile oncogenic factor for neuroblastoma associated with CpGi methylation within the third exon.
    Uekusa S; Kawashima H; Sugito K; Yoshizawa S; Shinojima Y; Igarashi J; Ghosh S; Wang X; Fujiwara K; Ikeda T; Koshinaga T; Soma M; Nagase H
    Int J Oncol; 2014 May; 44(5):1669-77. PubMed ID: 24626568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
    Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
    Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of CpG sites at the promoter region is associated with deregulation of mitochondrial ATPsyn-β and chemoresistance in acute myeloid leukemia.
    Yang J; Xiao X; Li R; Li Z; Deng M; Zhang G
    Cancer Biomark; 2016; 16(1):81-8. PubMed ID: 26835708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation status of the promoter region of the human frizzled 9 gene in acute myeloid leukemia.
    Zhang Y; Jiang Q; Kong X; Yang L; Hu W; Lv C; Li Y
    Mol Med Rep; 2016 Aug; 14(2):1339-44. PubMed ID: 27314612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
    Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
    Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer.
    Yeh CM; Chang LY; Lin SH; Chou JL; Hsieh HY; Zeng LH; Chuang SY; Wang HW; Dittner C; Lin CY; Lin JM; Huang YT; Ng EK; Cheng AS; Wu SF; Lin J; Yeh KT; Chan MW
    Sci Rep; 2016 Aug; 6():31690. PubMed ID: 27528092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15(Ink4b)-deficient mice.
    Wolff L; Garin MT; Koller R; Bies J; Liao W; Malumbres M; Tessarollo L; Powell D; Perella C
    Oncogene; 2003 Dec; 22(58):9265-74. PubMed ID: 14681685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis.
    Lin SC; Yao CY; Hsu CA; Lin CT; Calkins MJ; Kuo YY; Tang JL; Tien HF; Wu SJ
    Ann Hematol; 2022 Oct; 101(10):2209-2218. PubMed ID: 36040481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
    Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
    Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
    Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.
    Tagde A; Rajabi H; Stroopinsky D; Gali R; Alam M; Bouillez A; Kharbanda S; Stone R; Avigan D; Kufe D
    Oncotarget; 2016 Jun; 7(26):38974-38987. PubMed ID: 27259275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice.
    Ramirez-Herrick AM; Mullican SE; Sheehan AM; Conneely OM
    Blood; 2011 Mar; 117(9):2681-90. PubMed ID: 21205929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
    Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.